-
Welcome to Celiac.com!
You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.
-
Celiac.com Sponsor (A1):
Celiac.com Sponsor (A1-M):
-
Get Celiac.com Updates:Support Our Content
Search the Community
Showing results for tags 'global'.
Found 17 results
-
Celiac.com 10/12/2023 - Celiac disease is a chronic, inflammatory disease triggered by the consumption of gluten-containing foods. Early diagnosis and proper management with a gluten-free diet can reduce its impact on patients' quality of life. People with a family history of celiac disease are at a higher risk, making it crucial to actively identify cases within this group. A new study conducted by a team of researchers in Australia offers new insight into rates of celiac disease, particularly among first-degree relatives of individuals with the condition. The research team included Richard Muir, Anuj Sehgal, Jason A Tye‐Din and A James M Daveson. They are variously affiliated with The Wesley Hospital, Brisbane, QLD; St Andrew's War Memorial Hospital, Brisbane, QLD; the Wesley Research Institute, Brisbane, QLD; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC; The Royal Melbourne Hospital, Melbourne, VIC; and The University of Queensland, Brisbane, QLD. Celiac Disease Affects Approximately 1.4% of People Globally Their research found that celiac disease affects approximately 1.4% of both the global and Australian populations. The study, conducted at the Wesley Research Institute in Brisbane, targeted first-degree relatives of individuals already diagnosed with celiac disease. These relatives were invited to participate in the research, and the study involved genetic testing for celiac disease risk alleles (HLA‐DQ2/8/7 polymerase chain reaction genotyping) and serological tests to detect specific antibodies related to celiac disease. Key findings from the study include: High Celiac Disease Susceptibility Among the participants, 86% had celiac disease susceptibility haplotypes, with 50% of children and 53% of adults carrying high-risk celiac-associated genotypes. Serology Results Sixteen individuals with susceptibility haplotypes tested positive for serological markers associated with celiac disease. Biopsy Confirmation Small bowel biopsies were performed on individuals with positive serological results, confirming celiac disease in seven children and two adults who had high-risk alleles. Celiac Disease Prevalence Among Child First-Degree Relatives Between 11% and 14% Among child first-degree relatives, the estimated rates of celiac disease was 11%, rising to 14% among those with celiac disease susceptibility haplotypes. In contrast, only 1.4% of adult first-degree relatives were confirmed to have celiac disease. These findings highlight the importance of active case finding, especially among first-degree relatives of individuals diagnosed with celiac disease. Such screening can lead to early diagnosis and timely intervention, improving the quality of life and health for celiacs. However, the study also acknowledges limitations, including the fact that not all individuals with positive serological results underwent small bowel biopsies. Additionally, the research was conducted at a single center, and a non-first-degree relatives group was not included for comparison. Overall, the study's results support international guidelines recommending active case finding among first-degree relatives of individuals with celiac disease. Read more in The Medical Journal Of Australia -
Celiac.com 12/01/2020 - Lipase is an enzyme that breaks down fats into glycerol and fatty acids, which can help reduce the possibility of obesity and weight gain. The global market for Lipase enzyme is projected to grow substantially over the next decade, largely as a result of the increased production of food and dairy products. Increasing consumption of fatty and carbohydrate rich food items has helped drive an increase in health-related diseases, like obesity and celiac disease, but also in adverse symptoms such as bloating, abdominal discomfort and indigestion. According to the World Health Organization, nearly 40% of adults aged 18 years and over are overweight, while nearly 15% are obese. Rising numbers of people with obesity, celiac disease, high cholesterol, and high triglycerides, along with a desire to reduce rates of health diseases have helped increase global demand for Lipase enzyme. In addition to the healthcare industry, where emerging biosensors technology is expected to drive lucrative growth opportunities, Lipase enzyme also enjoys rising demand from the food and dairy industry as a flavor enhancer. A recent report by Futuremarketinsights.com, Lipase enzyme Market Latest Technology and Market Trends & Forecast – 2028, offers in-depth insights on crucial aspects of the global Lipase enzyme market and offers insight on important market segments, growth and competition patterns, along with other factors fueling market growth. Get a sample of the report, Lipase enzyme Market Latest Technology and Market Trends & Forecast – 2028. Read more at kerryvillebreakingnews.com -
View full article
-
Celiac.com 11/19/2019 - Driven in part by perceptions of better health and nutrition, sales of gluten-free snacks remains strong, though the paleo category is rising fast. That's leading to some evolution, and even some overlap, within these categories. According to a SPINS 2019 “State of the Industry” report, paleo and grain-free food and beverages are showing the fastest growth in conventional retail. The paleo diet has nothing to do with food intolerance, but instead touts the perceived healthiness of certain "paleo" foods. Paleo-positioned foods grew 48.8% to $294 million in conventional retail sales compared to the previous year, while the grain-free category grew 81.5% to $139.4 million over the previous year. The biggest growth was seen in the chip, pretzel, and snack categories, which saw paleo products grow 163.5% to $41.1 million in sales and grain-free snack sales grow 258.3% to $29.7 million. Consumers who do not suffer from celiac disease, which affects only about 1 in 100 people, are driving the growth of gluten-free and paleo foods, in part because of the belief that such foods are healthier and more nutritious than their gluten-containing counterparts. By all projections, though they may morph into many hybrid forms of cross-category products, such as "Gluten-Free Paleo," gluten-free foods and snacks will likely continue their popularity into the foreseeable future. Read more at nutritionaloutlook.com. -
View full article
-
Celiac.com 06/18/2018 - Celiac disease has been mainly associated with Caucasian populations in Northern Europe, and their descendants in other countries, but new scientific evidence is beginning to challenge that view. Still, the exact global prevalence of celiac disease remains unknown. To get better data on that issue, a team of researchers recently conducted a comprehensive review and meta-analysis to get a reasonably accurate estimate the global prevalence of celiac disease. The research team included P Singh, A Arora, TA Strand, DA Leffler, C Catassi, PH Green, CP Kelly, V Ahuja, and GK Makharia. They are variously affiliated with the Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Lady Hardinge Medical College, New Delhi, India; Innlandet Hospital Trust, Lillehammer, Norway; Centre for International Health, University of Bergen, Bergen, Norway; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Gastroenterology Research and Development, Takeda Pharmaceuticals Inc, Cambridge, MA; Department of Pediatrics, Università Politecnica delle Marche, Ancona, Italy; Department of Medicine, Columbia University Medical Center, New York, New York; USA Celiac Disease Center, Columbia University Medical Center, New York, New York; and the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India. For their review, the team searched Medline, PubMed, and EMBASE for the keywords ‘celiac disease,’ ‘celiac,’ ‘tissue transglutaminase antibody,’ ‘anti-endomysium antibody,’ ‘endomysial antibody,’ and ‘prevalence’ for studies published from January 1991 through March 2016. The team cross-referenced each article with the words ‘Asia,’ ‘Europe,’ ‘Africa,’ ‘South America,’ ‘North America,’ and ‘Australia.’ They defined celiac diagnosis based on European Society of Pediatric Gastroenterology, Hepatology, and Nutrition guidelines. The team used 96 articles of 3,843 articles in their final analysis. Overall global prevalence of celiac disease was 1.4% in 275,818 individuals, based on positive blood tests for anti-tissue transglutaminase and/or anti-endomysial antibodies. The pooled global prevalence of biopsy-confirmed celiac disease was 0.7% in 138,792 individuals. That means that numerous people with celiac disease potentially remain undiagnosed. Rates of celiac disease were 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania; the prevalence was 0.6% in female vs 0.4% males. Celiac disease was significantly more common in children than adults. This systematic review and meta-analysis showed celiac disease to be reported worldwide. Blood test data shows celiac disease rate of 1.4%, while biopsy data shows 0.7%. The prevalence of celiac disease varies with sex, age, and location. This review demonstrates a need for more comprehensive population-based studies of celiac disease in numerous countries. The 1.4% rate indicates that there are 91.2 million people worldwide with celiac disease, and 3.9 million are in the U.S.A. Source: Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2. doi: 10.1016/j.cgh.2017.06.037. -
Celiac.com 08/04/2017 - Industry analysts are projecting the global market for gluten-free pet foods to enjoy growth of up to 25% a year over the next decade. Across numerous industries, a shift from products containing gluten to gluten-free products is creating major potential for manufacturers. The latest market report from Persistence Market Researchers, titled Global Gluten-free Pet Food Market: Drivers and Restraints, projects double-digit growth in gluten-free pet food markets through 2025. The report offers market information and analysis on all segments of the global gluten-free pet food market broken down by type, flavor, specification, form, and distribution channel. Types include natural and added additives, while flavor types are further divided into chicken, beef, fish, and other red meat and white meats. Specification covers the type of pet, such as food for cats, for dogs, for birds, for pocket animals, and others. The report breaks down each of these categories. In terms of distribution channel, the global gluten-free pet food market report includes information on e-commerce, supermarkets, retail shops, exclusive pet shops, and others. Form type includes information on dry and wet pet food market segments. Gluten-free pet food is a new segment in the pet food industry, and has strong potential to displace regular pet foods. North America currently leads the world in gluten-free pet food production. Currently, there are no gluten-free pet food manufacturers in Europe. Meanwhile, North America and Europe are currently the largest consumers of gluten-free pet food products followed by Asia Pacific. A Sample of this Report is Available Upon Request at: PersistenceMarketResearch.com -
Celiac.com 05/13/2017 - Currently, a gluten-free diet is the only treatment recommended for people with celiac disease, or other medical sensitivities to gluten, especially those who show symptoms of gluten intolerance, such as vomiting and chronic diarrhea. Those folks may be in for a pleasant surprise, as the global market for various types of gluten-free flours looks set to takeoff over the next few years, driven in part by gluten-free flours made from amaranth, corn, maize, coconut and/or beans, among others. Gluten-free flours offer a number of benefits, including very high protein, good texture, and, in many cases, higher nutritional value and fiber content, compared with other grains. Many gluten-free flours make an excellent thickener for soups and sauces, and a good addition to all purpose of baking flour. Overall, the rapid growth of the global market for gluten-free flours is due, at least in part, to increasing popularity within the processed food industry, growing urbanization and an increase in demand by an aging population. Another major factor is a growing concern with health-related issues, such as obesity, diabetes, and weight management, among others. These, along with perceived generic health benefits are expected to drive a rapidly increasing demand for gluten-free flours in the coming years. However, lack of awareness in developing countries regarding the need and benefits of gluten free flours, along with the high cost of gluten free flours, as compared to wheat flours, may serve to dampen expected growth in the gluten-free flours market in near future. Driven partly by ready availability, demand for gluten-free flours will come mainly from the fast growing bakery sector, especially as products like gluten-free biscuits become more popular, spurring the use of gluten free flours ingredients such as bean flour, chia seeds, and nut flours along with binders such as guar gum, xanthan, and baking powder. Lastly, market analysts expect the commercial availability of pre-mixed gluten-free flour mixes to increase both supply and demand for gluten-free baked goods. Source: OpenPR.com -
Celiac.com 04/28/2017 - The global market for new drugs to treat celiac disease is set to surge strongly by 2021, according to the latest market report from Persistence Market Research. The company's Celiac Drugs Market report offers in-depth analysis of overall market trends, macro-economic indicators, and governing factors, along with the projected strength of individual market segments. The report also offers geographical breakdowns of the various market factors and the specific market segments they influence. Key factors influencing global market growth of celiac drugs include increased healthcare expenditures, changing lifestyles, growing healthcare awareness, and an increase in incentive by various governments and government associations. However, complex regulatory frameworks govern drug approval in most countries, and could limit or slow the global market growth for celiac drugs. That global celiac drug market is currently dominated by North America, in part due to rising celiac diagnosis, coupled with limited treatment options. In the next five years, the Asia-Pacific region will emerge as a major market for celiac drugs, with China and India seeing the bulk of the growth. Key forces driving the celiac drug market in developing countries include the large pool of patients, increasing awareness about the disease, and rising government funding in the region. Rapid innovation of drugs to effectively treat celiac disease presents tremendous opportunity for the global drug market. The major companies developing celiac drugs for the global market are Alvine Pharmaceuticals, Inc., Alba Therapeutics Corporation, ImmusanT, and the Institute for Protein Design. These are among numerous companies looking to develop, perfect market drugs treatments for celiac disease over the next few years. View more of the report at: PersistenceMarketResearch.com -
Celiac.com 04/01/2017 - Global Market Insights has just released its latest report on global gluten free food markets. The report is entitled Gluten Free Food Market Size, Industry Outlook Report, Regional Analysis (U.S., Germany, UK, Italy, Russia, China, India, Japan, South Korea, Brazil, Mexico, Saudi Arabia, UAE, South Africa), Downstream Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023. The report uses comprehensive data to generate reports on gluten free markets and market segments through 2023. Some of the more general insights include: The global gluten free food market size was about 350,000 tons in 2014, and current report estimates that it will grow at a CAGR of more than 9%, to likely exceed 750 kilo tons by 2023. The market was valued at over 4 billion in 2014 and is likely to be worth more than 9 billion by 2023, growing at an estimated CAGR of over 10%. The largest sector was gluten-free bakery products, with 55% of the total market volume in 2014. The gluten-free bakery sector is set to see more than 7% growth through 2023. Cereals & snacks, pizzas, pastas and savories are all likely to show higher growth rates over the forecast period. With over 50% of the total gluten-free market by volume in 2014, the EU will continue to be a major player in the global gluten free food market. North America generated about 20% of total market volume in 2014, and is likely to show strong growth through 2023. The last major insight in their summary included the acknowledgement that the global gluten free food market share is only moderately consolidated among major companies, such as Kellogg’s Company, Boulder Brands, Dr Schar., Hain Celestial, Freedom Foods Group and General Mills. There is still room to grow, and room for consolidation, so look for potential synergy between major players and other prominent companies, such as Ener-G Foods and Genius Foods Ltd, Raisio PLC, Valeo Foods, Hero Group Ag and Kraft Heinz Company. The full report is available for purchase at GMInsights.com -
Celiac.com 03/06/2014 - Celiac disease is associated with various nutritional and reproductive issues, and increased risk of thyroid disease, kidney failure and certain cancers. For reasons yet unknown, over the last forty years, celiac disease, gluten intolerance and irritable bowel syndrome, have climbed to epidemic proportions. Is the rapid worldwide increase in celiac disease, gluten intolerance and irritable bowel syndrome a result of the rising use of Monsanto's glyphosate herbicide, sold as Roundup? Yes, according to a new US peer-reviewed paper from Dr. Anthony Samsel and Dr. Stephanie Seneff. Their research indicates that glyphosate is the primary cause of an emerging epidemic of celiac disease, gluten intolerance and irritable bowel syndrome. Their review appears in the Journal of Interdisciplinary Toxicology. According to Samsel and Seneff, glyphosate, the active ingredient in the herbicide, Roundup, "is the most important causal factor" in the global epidemic of celiac disease, gluten intolerance and irritable bowel syndrome. Stay tuned for more detailed summary of the nature, scope, methodology, and findings of the study itself. In the meantime, read the complete original review at sustainablepulse.com. -
Celiac.com 04/14/2016 - Driven partly by a perception among consumers that gluten-free foods are healthier than their non-gluten-free counterparts, the global gluten-free packaged food market is projected to grow at a compound annual growth rate of approximately 6% between 2015 and 2019, according to a recent market report from Technavio. In addition to health and wellness, Technavio identifies demand from millennials and increased marketing activities as prime emerging trends driving the gluten-free market. Once seen as medical products for gluten intolerant people gluten-free products have evolved into "a lifestyle choice across all customer segments," says Brijesh Kumar Choubey, a lead food industry analyst at Technavio. Many consumers associate gluten-free foods with better energy energy levels, and with weight loss. Technavio cites a 2013 market survey conducted by Monash University that revealed nearly 80% people buying gluten-free products report perceived health benefits as the main reason. Just five to ten years ago, buyers of gluten-free foods were likely to be older. Today, younger consumers, specifically 32% of millennials, and 38% of Generation Z, said they would pay higher prices for gluten-free products. Bakery products, cookies and snacks are the top gluten-free foods among this consumer group, said Technavio. Driven by growing demand, and by new product development, the bakery segment leads the gluten-free packaged food market with 64% market share in 2014. Technavio predicts the segment will outpace the rest of the market through the end of 2019, growing at a rate of about 7%. Increased marketing activities from big and small manufacturers alike is the last key driver Technavio cites as a driver for gluten-free packaged food demand. An example is Heinz, which in 2014 launched a social media campaign for its gluten-free pasta and sauces, Technavio said. Source: Foodbusinessnews.net
-
Celiac.com 12/18/2015 - Flour is a major global business, and flours of all kinds constitute a major part of the growing global food industry. Global flour markets are directly impacted by the growing processed food industry. Recent years have seen a notable expansion of the global flour market in terms of increased global demand and production capacity. Fueled by changing customer preference, increased health concerns related to high-protein flours, rising urbanization, and per-capita income of the global population, Transparency Market Research expects the global flour market, valued at USD 182.66 billion in 2013, to reach 183,100.0 kilo tons in the next five years, growing at a CAGR of 3.8% to top USD 245.82 billion by 2020. One of the big drivers of flour market growth is the rise in consumption of bread and bakery products and ready-to-eat (RTE) products in developing economies. Also, rising health concerns over high-protein flour provides an opportunity for flour millers to promote gluten-free, and low-protein variants of flours. The market for gluten-free products includes products such as breakfast cereals, gluten-free flour, snacks, and bakery products, among others. Considering that the demand for gluten-free variants of flour such as corn flour, soya flour, maize flour and rice flour is significant in the global market, analysts are projecting a strong rise in the popularity of gluten-free foods in the 2014-2020 forecast period. Browse Market Research Report of Flour Market.
-
Global Gluten-free Market Will Reach $6.2 Billion by 2018
Jefferson Adams posted an article in Additional Concerns
.webp.f93278c779444b77bcce02b848380bf3.webp)
Celiac.com 11/29/2013 - The worldwide market for gluten-free products market will continue to grow, reaching $6.2 billion by 2018, according to a new report from Markets and Markets. Gluten-free bakery and confectionery products represent 46% of total gluten-free product sales, followed by gluten-free snacks at 20%. The North American market racked up about 59% of total global gluten-free sales, according to the report. Conventional sales channels accounted for the highest volume of of global gluten-free product sales. Also, the trends show that major gluten-free players like Hain Celestial, Inc., General Mills, Inc., Amy’s Kitchen, Inc. and Boulder Brands will continue to have a heavy market presence into the foreseeable future. Source: foodbusinessnews.net -
Celiac.com 09/12/2013 - The most recent industry report by Research and Markets offers a comprehensive analysis of key players in the gluten-free product industry, major gluten-free product types and their sales channels, with commentary on developments and trends. The report also provides a detailed analysis on various phases of numerous aspects of the gluten-free products industry, along with the competitive strategies favored by major industry players. Among the reports insights: As large supermarkets and mass retailers offer more gluten-free products, gluten-free sales by health and natural food stores are declining. Over the last ten years, as millions of Americans have stopped consuming products containing gluten from wheat, barley, or rye, the market for gluten-free foods and other products has shifted, and many products once regarded as specialty or niche products are now regarded as regular grocery items. The report projects global gluten-free product market to reach $6.2 billion at a CAGR of 10.2% by 2018. The report also provides market details and analysis for North America, now the largest market for gluten-free products, and for Europe, which is expected to show significant growth in the market in the near future. Some of that growth is attributed to a steady stream of new gluten-free products in the market, offering additional nutrition, new ingredients or flavors. The also report projects increased demand countries such as U.K., Italy, U.S., Spain, Germany, Australia, Brazil, Canada, and India, among others. The full report is available for purchase at: Gluten-Free Products Market By Type (Bakery & Confectionery, Snacks, Breakfast Cereals, Baking Mixes & Flour, Meat & Poultry Products), Sales Channel (Natural & Conventional) & Geography — Global Trends & Forecasts To 2018
-
Celiac.com 08/05/2013 - It's well-publicized that the market for gluten-free products continues to experience double-digit growth. A new analysis of the various segments of the global gluten-free product market is helping researchers to better understand the finer aspects of the market, and to better forecast global volume and revenue prospects for gluten-free products. It also looks at the major forces both driving and impeding the global gluten-free product market. The report, called the "Gluten-Free Products Market By Type (Bakery & Confectionery, Snacks, Breakfast Cereals, Baking Mixes & Flour, Meat & Poultry Products), Sales Channel (Natural & Conventional) & Geography - Global Trends & Forecasts To 2018,"is issued by RnRMarketResearch.com. The report data is is broken down on the basis of geographic region, by gluten-free product type: bakery and confectionery; breakfast cereals; snacks; baking mixes and flour; meat and poultry products, or other gluten-free foods, such as sauces, dressings, beverages, dairy products, etc. It is also broken down by type of sales channel, that is natural health food stores, or conventional retailers. The data are further divided by chain or single store, grocery, mass merchandiser, club store, drug store, or other type of retailer, such as e-retailers, mail orders etc. According to the report, public perception that gluten-free foods are healthier than conventional products is the most important factor fueling gluten-free food sales. Other factors include ongoing improvement of gluten-free products, and increasing retail availability. Detracting from growth is the fact that many consumers do not know the difference between an allergy and intolerance, and many consumers remain undiagnosed for celiac disease, or gluten-intolerance. Be that as it may, the global gluten-free products market is projected to maintain a compound annual growth rate (CAGR) of 10.2%, and to exceed of $6.2 billion by 2018. Once again, the data show that gluten-free bakery and confectionery products account for the largest share of gluten-free product sales, at about 46%, followed by gluten-free snacks, which account for about 20%. During the time projected, the north American market will account for nearly 60% of total global gluten-free food revenues. Highest consumption of gluten-free product in the global market was through conventional sales channels. This rising demand and rising variety of goods has made chain supermarkets and mass merchandisers the preferred retail channel for gluten-free product purchases. Globally, the market for gluten-free products market has seen rapid growth, but nothing like the consistent double-digit growth seen in North America and Europe. There, companies The Hain Celestial Inc. (U.S.), General Mills Inc. (U.S.), Dr. Schar (Italy), Amy's Kitchen Inc. (U.S.), and Boulders Brand Inc. (U.S), have a huge influence on overall market dynamics. Source: rnrmarketresearch.com. -
Celiac.com 08/30/2011 - In a first of its kind study, a team of researchers is attempting a global estimate of the burden of celiac disease in childhood, and to to determine what role childhood celiac disease might play in global mortality due to diarrhea. The research team included Peter Byass, Kathleen Kahn, and Anneli Ivarsson. They are affiliated with the Umeå Centre for Global Health Research, Department of Public Health and Clinical Medicine at Umeå University in Umeå, Sweden, and with the MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences at University of the Witwatersrand in Johannesburg, South Africa. In the last several decades, celiac disease has become an an increasingly recognized public health problem. More recently, celiac disease has emerged as a global earth issue, in spite scant globally representative epidemiological data. Because children with celiac disease often have chronic diarrhea and malnutrition, a proper diagnosis is often missed, especially in poorer settings, where water-borne infectious diarrheas are common, and many children fail to thrive. To make their assessment, the two used available data to build a basic model of childhood celiac disease, incorporating estimates of population prevalence, probability of non-diagnosis, and likelihood of mortality among undiagnosed children of all countries from 1970 to 2010. In their paper, the two state the assumptions underlying their model, and make the model available as a supplementary file. Based on their model, in 2010 there were around 2.2 million children under 5 years of age living with celiac disease, while each year, there would be about 42,000 deaths related to celiac disease in these children. That would mean that, in 2008, deaths related to celiac disease likely totaled about 4% of all childhood diarrhea deaths worldwide. Even if celiac disease accounts for only a small proportion of global diarrhea deaths, these deaths are preventable, but not by normal diarrhea treatment, which can often involve gluten-based food supplements. They also note that, as other causes of diarrhea mortality decline, celiac disease will become a proportionately greater problem unless clinicians begin to try gluten-free diets for children with chronic diarrhea and malnutrition. Source: PLoS One. 2011; 6(7): e22774. doi: 10.1371/journal.pone.0022774
Celiac.com Sponsor (A8):
Celiac.com Sponsor (A8):
Celiac.com Sponsor (A8-M):
Celiac.com Sponsor (A8):
Celiac.com Sponsor (A8):
Celiac.com Sponsor (A8-M):